Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 100

1.

Protein signatures correspond to survival outcomes of AJCC stage III melanoma patients.

Mactier S, Kaufman KL, Wang P, Crossett B, Pupo GM, Kohnke PL, Thompson JF, Scolyer RA, Yang JY, Mann GJ, Christopherson RI.

Pigment Cell Melanoma Res. 2014 Nov;27(6):1106-16. doi: 10.1111/pcmr.12290. Epub 2014 Aug 14.

PMID:
24995518
[PubMed - in process]
Free Article
2.

Surface antigen profiles of leukocytes and melanoma cells in lymph node metastases are associated with survival in AJCC stage III melanoma patients.

Kaufman KL, Mactier S, Armstrong NJ, Mallawaaratchy D, Byrne SN, Haydu LE, Jakrot V, Thompson JF, Mann GJ, Scolyer RA, Christopherson RI.

Clin Exp Metastasis. 2014 Jan 17. [Epub ahead of print]

PMID:
24435119
[PubMed - as supplied by publisher]
Free PMC Article
3.

N-ratio: a novel independent prognostic factor for patients with stage-III cutaneous melanoma.

Rossi CR, Mocellin S, Pasquali S, Pilati P, Nitti D.

Ann Surg Oncol. 2008 Jan;15(1):310-5. Epub 2007 Nov 7.

PMID:
17987346
[PubMed - indexed for MEDLINE]
4.

Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients.

Mian S, Ugurel S, Parkinson E, Schlenzka I, Dryden I, Lancashire L, Ball G, Creaser C, Rees R, Schadendorf D.

J Clin Oncol. 2005 Aug 1;23(22):5088-93.

PMID:
16051955
[PubMed - indexed for MEDLINE]
Free Article
5.

The number of excised lymph nodes is associated with survival of melanoma patients with lymph node metastasis.

Rossi CR, Mozzillo N, Maurichi A, Pasquali S, Quaglino P, Borgognoni L, Solari N, Piazzalunga D, Mascheroni L, Giudice G, Mocellin S, Patuzzo R, Caracò C, Ribero S, Marone U, Santinami M.

Ann Oncol. 2014 Jan;25(1):240-6. doi: 10.1093/annonc/mdt510.

PMID:
24356635
[PubMed - indexed for MEDLINE]
6.

Predicting clinical outcome through molecular profiling in stage III melanoma.

John T, Black MA, Toro TT, Leader D, Gedye CA, Davis ID, Guilford PJ, Cebon JS.

Clin Cancer Res. 2008 Aug 15;14(16):5173-80. doi: 10.1158/1078-0432.CCR-07-4170.

PMID:
18698035
[PubMed - indexed for MEDLINE]
Free Article
7.

Association between circulating tumor cells and prognosis in patients with stage III melanoma with sentinel lymph node metastasis in a phase III international multicenter trial.

Hoshimoto S, Shingai T, Morton DL, Kuo C, Faries MB, Chong K, Elashoff D, Wang HJ, Elashoff RM, Hoon DS.

J Clin Oncol. 2012 Nov 1;30(31):3819-26. doi: 10.1200/JCO.2011.40.0887. Epub 2012 Sep 24.

PMID:
23008288
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Estimates of stage-specific survival are altered by changes in the 2002 American Joint Committee on Cancer staging system for melanoma.

Ben-Porat L, Panageas KS, Hanlon C, Patel A, Halpern A, Houghton AN, Coit D.

Cancer. 2006 Jan 1;106(1):163-71.

PMID:
16331596
[PubMed - indexed for MEDLINE]
Free Article
9.

Prognostic heterogeneity after the excision of lymph node metastases in patients with cutaneous melanoma.

Pilko G, Besic N, Zgajnar J, Hocevar M.

Surg Oncol. 2011 Mar;20(1):26-34. doi: 10.1016/j.suronc.2009.09.004. Epub 2009 Nov 8. Review.

PMID:
19900803
[PubMed - indexed for MEDLINE]
10.

Expression of p16 in lymph node metastases of adjuvantly treated stage III colorectal cancer patients identifies poor prognostic subgroups: a retrospective analysis of biomarkers in matched primary tumor and lymph node metastases.

Karamitopoulou E, Zlobec I, Koumarianou A, Patsouris ES, Peros G, Lugli A.

Cancer. 2010 Oct 1;116(19):4474-86. doi: 10.1002/cncr.25304.

PMID:
20572035
[PubMed - indexed for MEDLINE]
Free Article
11.

Molecular and biochemical testing in stage III melanoma: multimarker reverse transcriptase-polymerase chain reaction assay of lymph fluid after lymph node dissection and preoperative serum lactate dehydrogenase level.

Nowecki ZI, Rutkowski P, Kulik J, Siedlecki JA, Ruka W.

Br J Dermatol. 2008 Sep;159(3):597-605. doi: 10.1111/j.1365-2133.2008.08710.x. Epub 2008 Jul 4.

PMID:
18616789
[PubMed - indexed for MEDLINE]
12.

Whole genome methylation profiles as independent markers of survival in stage IIIC melanoma patients.

Sigalotti L, Covre A, Fratta E, Parisi G, Sonego P, Colizzi F, Coral S, Massarut S, Kirkwood JM, Maio M.

J Transl Med. 2012 Sep 5;10:185. doi: 10.1186/1479-5876-10-185.

PMID:
22950745
[PubMed - indexed for MEDLINE]
Free PMC Article
13.

Serum amyloid A as a prognostic marker in melanoma identified by proteomic profiling.

Findeisen P, Zapatka M, Peccerella T, Matzk H, Neumaier M, Schadendorf D, Ugurel S.

J Clin Oncol. 2009 May 1;27(13):2199-208. doi: 10.1200/JCO.2008.18.0554. Epub 2009 Mar 23.

PMID:
19307507
[PubMed - indexed for MEDLINE]
Free Article
14.

A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.

Langan RC, Mullinax JE, Ray S, Raiji MT, Schaub N, Xin HW, Koizumi T, Steinberg SM, Anderson A, Wiegand G, Butcher D, Anver M, Bilchik AJ, Stojadinovic A, Rudloff U, Avital I.

J Cancer. 2012;3:231-40. doi: 10.7150/jca.4542. Epub 2012 Jun 1.

PMID:
22670157
[PubMed]
Free PMC Article
15.

High expression of glycolytic and pigment proteins is associated with worse clinical outcome in stage III melanoma.

Falkenius J, Lundeberg J, Johansson H, Tuominen R, Frostvik-Stolt M, Hansson J, Egyhazi Brage S.

Melanoma Res. 2013 Dec;23(6):452-60. doi: 10.1097/CMR.0000000000000027.

PMID:
24128789
[PubMed - indexed for MEDLINE]
16.

Contemporary surgical treatment of advanced-stage melanoma.

Essner R, Lee JH, Wanek LA, Itakura H, Morton DL.

Arch Surg. 2004 Sep;139(9):961-6; discussion 966-7.

PMID:
15381613
[PubMed - indexed for MEDLINE]
17.

Lymph-vascular space invasion and number of positive para-aortic node groups predict survival in node-positive patients with endometrial cancer.

Watari H, Todo Y, Takeda M, Ebina Y, Yamamoto R, Sakuragi N.

Gynecol Oncol. 2005 Mar;96(3):651-7.

PMID:
15721407
[PubMed - indexed for MEDLINE]
18.

Nomograms to predict recurrence and survival in stage IIIB and IIIC melanoma after therapeutic lymphadenectomy.

Khosrotehrani K, van der Ploeg AP, Siskind V, Hughes MC, Wright A, Thomas J, Barbour A, Allan C, Bayley G, Eggermont A, Verhoef C, Smithers BM, Green AC.

Eur J Cancer. 2014 May;50(7):1301-9. doi: 10.1016/j.ejca.2014.02.010. Epub 2014 Mar 6.

PMID:
24613127
[PubMed - indexed for MEDLINE]
19.

Limitations of lymph node ratio, evidence-based benchmarks, and the importance of a thorough lymph node dissection in melanoma.

Grotz TE, Huebner M, Pockaj BA, Perkins S, Jakub JW.

Ann Surg Oncol. 2013 Dec;20(13):4370-7. doi: 10.1245/s10434-013-3186-0. Epub 2013 Sep 18.

PMID:
24046102
[PubMed - indexed for MEDLINE]
20.

A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III).

Balch CM, Soong SJ, Murad TM, Smith JW, Maddox WA, Durant JR.

J Clin Oncol. 1983 Feb;1(2):126-34.

PMID:
6668496
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk